Prosecution Insights
Last updated: October 04, 2026

Biodot Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Biodot Inc. currently has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This matter is assigned to 1 distinct examiner, creating a direct and centralized prosecution path. The activity is confined to 1 distinct art unit, which suggests that the technical subject matter is being evaluated by a specialized group within the patent office. This arrangement allows the applicant to focus their technical arguments on the specific standards used by this 1 art unit.

GRAVINI, STEPHEN MICHAEL is the busiest examiner for the company, with 1 pending office action currently under review. Because the busiest examiner pending count of 1 matches the total number of pending actions, this examiner's evaluation will determine the immediate outcome for the pending portfolio. Practitioners should analyze the specific trends of this 1 examiner to effectively navigate the requirements of the 1 art unit involved. The success of the 1 pending action depends entirely on addressing the concerns of this single examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GRAVINI, STEPHEN MICHAEL 1 77.9% +19.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18184493 LYOPHILIZED BEAD MANUFACTURING SYSTEM AND METHODS GRAVINI, STEPHEN MICHAEL 15d

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18184493 LYOPHILIZED BEAD MANUFACTURING SYSTEM AND METHODS GRAVINI, STEPHEN MICHAEL 15d

Top Art Units

Art UnitApps
3753 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18184493 LYOPHILIZED BEAD MANUFACTURING SYSTEM AND METHODS GRAVINI, STEPHEN MICHAEL 3753 §102§103 Final Rejection 15d Pending Mar 15, 2023

Managing Biodot Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month